Pneumococcal vaccine

2022 - 12 - 19

Post cover
Image courtesy of "Korea Biomedical Review"

Boryung Biopharma to supply MSD Korea's pneumococcal vaccine (Korea Biomedical Review)

MSD Korea said on Monday that it has selected Boryung Biopharma as the new distributor and supplier of its pneumococcal vaccine, Prodiax 23.

MSD's 23-valent polysaccharide pneumococcal vaccine Prodiax 23 was licensed in Korea in 2000. "As public interest in respiratory-related infectious diseases has increased, interest and demand for our pneumococcal vaccines have also increased,” MSD Korea’s Executive Director of the Vaccine Division Cho Jae-yong said. “The contract was made to immediately and actively respond to these demands and we will try to stably supply MSD Prodiax 23 to more patients to contribute to the prevention of pneumococcal infectious diseases."

Explore the last week